日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers

Sovleplenib 的发现:一种选择性 Syk 抑制剂,目前正处于治疗自身免疫性疾病和癌症的临床开发阶段

Jia, Hong; Deng, Wei; Hao, Baoyu; Cai, Min; Guo, Dong; Cai, Yu; Dai, Xiaoming; Wu, Zhipeng; He, Weigang; Wang, Jian; Wang, Guanglin; Xia, Sumei; Li, Na; Su, Weiguo; Dai, Guangxiu

Withdrawal: The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway

撤退:溶酶体相关凋亡诱导蛋白(LAPF)含有pleckstrin同源结构域(PH)和FYVE结构域,代表了一类新型的含PH和FYVE结构域蛋白,它通过溶酶体-线粒体途径诱导不依赖于caspase的细胞凋亡。

Chen, Wei; Li, Nan; Chen, Taoyong; Han, Yanmei; Li, Changfei; Wang, Yuzhen; He, Weigang; Zhang, Lihuang; Wan, Tao; Cao, Xuetao

MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation.

MCL通过抑制NF-κB和NLRP3炎症小体的激活,在结核分枝杆菌诱导的免疫反应中发挥抗炎作用

Zhang Qingwen, Jiang Xinru, He Weigang, Wei Kailin, Sun Jinxia, Qin Xiangyang, Zheng Yuejuan, Jiang Xin

Micheliolide provides protection of mice against Staphylococcus aureus and MRSA infection by down-regulating inflammatory response.

米歇利醇通过下调炎症反应,保护小鼠免受金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌感染

Jiang Xinru, Wang Yuli, Qin Yifei, He Weigang, Benlahrech Adel, Zhang Qingwen, Jiang Xin, Lu Zhenhui, Ji Guang, Zheng Yuejuan